• Bifendate (DDB): Mechanistic Leadership in Hepatoprotection

  2026-07-31

  Discover how Bifendate (DDB) transforms translational liver research by precisely modulating autophagy and lipid metabolism. This article provides mechanistic insight, strategic protocol guidance, and a forward-looking perspective for researchers aiming to bridge preclinical findings to impactful clinical solutions.

• Cy7 NHS Ester: Protocols for Near-Infrared Protein Labeling

  2026-07-31

  Cy7 NHS ester addresses challenges in protein and peptide labeling by offering a water-soluble, sulfonated near-infrared dye suitable for sensitive, low-background imaging. It is optimal for workflows requiring minimal organic co-solvents and rapid labeling but is not appropriate when long-term dye solutions or non-NIR wavelengths are necessary.

• Olaparib (AZD2281, Ku-0059436): Reliable Solutions for BRCA-

  2026-07-30

  This article addresses practical laboratory challenges in DNA damage response, tumor radiosensitization, and BRCA-associated cancer research, demonstrating how Olaparib (AZD2281, Ku-0059436) (SKU A4154) from APExBIO delivers reproducible, data-driven results. Scenario-driven Q&A blocks illustrate validated protocols, compatibility, and product selection strategies for maximizing assay reliability.

• Sulfo-Cy5 Carboxylic Acid: Versatile Fluorescent Dye for Lif

  2026-07-30

  Sulfo-Cy5 carboxylic acid stands out as a hydrophilic, high-sensitivity fluorescent dye for robust protein and peptide labeling, especially in aqueous environments. Its unique physicochemical properties minimize fluorescence quenching and streamline imaging workflows, making it an asset for advanced immunology and neuroscience research.

• GOT1 Inhibition by Ziprasidone Reprograms Glutamine Metaboli

  2026-07-29

  This study identifies ziprasidone as a potent non-competitive inhibitor of GOT1, disrupting glutamine metabolism and redox balance in pancreatic ductal adenocarcinoma (PDAC) cells. The findings highlight metabolic reprogramming via GOT1 inhibition as a promising strategy for suppressing tumor growth and underscore the importance of redox regulation in cancer biology.

• Carvedilol Beyond Cardioprotection: Mechanistic Insights for

  2026-07-29

  Explore the diverse applications of Carvedilol as a β-adrenergic receptor antagonist in advanced vascular and hematopoietic research. This article uncovers novel mechanistic insights and practical assay guidance, distinguishing itself from existing protocol and translational guides.

• Fulvestrant (ICI 182,780): Mechanistic Leverage and Translat

  2026-07-28

  This article unpacks the unique mechanistic profile and translational impact of Fulvestrant (ICI 182,780) in ER-positive breast cancer research. Integrating post-translational MDM2 regulation, apoptosis induction, and immune crosstalk insights, it delivers actionable guidance and strategic perspective for researchers tackling endocrine therapy resistance and chemotherapy sensitization, while positioning APExBIO’s Fulvestrant as an essential tool for advanced studies.

• Amphotericin B: Protocol Innovations for Fungal Infection Re

  2026-07-28

  Amphotericin B, a polyene antifungal antibiotic, is central to advanced fungal infection research due to its potent ergosterol-targeting mechanism. Recent breakthroughs reveal synergistic strategies and refined protocols that maximize efficacy while minimizing toxicity, empowering reproducible translational workflows.

• GS-441524 Prodrug Workflows: Applied Protocols & Troubleshoo

  2026-07-27

  GS-441524 is redefining antiviral research with robust, LC–MS/MS-enabled workflows and improved prodrug conversion strategies. This article unpacks experimental setups, stepwise protocols, and real-world troubleshooting to empower more reliable, translational SARS-CoV-2 inhibitor studies.

• TMEM16F in Kupffer Cells Restricts Listeria-Induced Liver In

  2026-07-27

  This study identifies TMEM16F expression in liver Kupffer cells as a critical factor limiting tissue damage and metabolic disruption during Listeria monocytogenes infection. By demonstrating cell-type-specific membrane repair and the regulation of inflammatory signaling, the research clarifies how host responses restrain excessive inflammation and offers new avenues for dissecting hepatic immune defense.

• Prenatal Esketamine Exposure Impairs Neurodevelopment via Re

  2026-07-26

  This study demonstrates that prenatal administration of esketamine in rats leads to lasting deficits in offspring neurobehavior, associated with impaired neuronal proliferation and maturation. Through careful use of cell proliferation assays, the research reveals mechanistic links between esketamine exposure and compromised hippocampal function.

• CYP3A4 Genotype Alters Bifendate–Cyclosporine Interaction in

  2026-07-25

  This study demonstrates that Bifendate (DDB), a hepatoprotective agent, induces clinically significant, genotype-dependent reductions in cyclosporine plasma concentration by modulating CYP3A4 activity. The findings clarify a key pharmacokinetic drug–drug interaction and have important implications for research and clinical management in hepatology and transplantation.

• Ferroptosis-Gene Signature and Atorvastatin in HCC Prognosis

  2026-07-24

  This study establishes a four-gene ferroptosis-related prognostic signature for hepatocellular carcinoma and validates Atorvastatin as a potent ferroptosis inducer in HCC models. The findings offer a robust framework for precision oncology targeting ferroptosis pathways and highlight Atorvastatin’s translational relevance beyond cholesterol regulation.

• Streptozotocin: Precision Modeling of Diabetes and Neuroinfl

  2026-07-24

  Explore how Streptozotocin enables advanced diabetes research and neuroinflammatory studies. This article reveals its mechanistic precision, protocol nuances, and translational value—distinct from standard guides—anchored by recent breakthroughs in diabetic neuropathy models.

• Tetrandrine Alkaloid: Mechanistic Leverage for Translational

  2026-07-23

  This thought-leadership article unpacks the mechanistic and strategic value of Tetrandrine alkaloid as a precision research tool for ion channel, inflammation, and cancer biology studies. Blending recent mechanistic insights with actionable guidance, we chart a pragmatic path for translational researchers aiming to maximize data quality and cross-domain relevance. The article critically evaluates the biological rationale, experimental workflows, competitive landscape, and translational implications of Tetrandrine, referencing key studies and internal resources to provide a uniquely integrative perspective.

445 records 9/30 page Previous Next First page 上5页 678910 下5页 Last page